Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature — PRENECAL

Nephrocalcinosis Clinical Trial

Official title:
Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature.

Status Not yet recruiting

Clinical Trial Summary

Study to assess the efficacy and safety of oral potassium citrate on the Prevention of nephrocalcinosis in extreme premature: a clinical trial, randomized, double-blind placebo controlled trial.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Nephrocalcinosis

Clinical Trial Details

NCT number	NCT01756547
Study type	Interventional
Source	Hospital Clinic of Barcelona
Contact	Judit Pich Martínez, Pharmacist
Phone	0034 93 227 54 00
Email	jpich@clinic.ub.es
Status	Not yet recruiting
Phase	Phase 3
Start date	January 2013
Completion date	January 2014

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT00875823` - International Registry for Primary Hyperoxaluria	N/A
Completed	`NCT04382976` - The Incidence and the Risk Factors of Nephrocalcinosis in Very Preterm Infants
Completed	`NCT00249951` - Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants	Phase 3
Recruiting	`NCT00169806` - Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis	N/A
Not yet recruiting	`NCT05862207` - Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital
Recruiting	`NCT04495608` - Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels	Phase 2
Completed	`NCT02438267` - Preterm Infants and Nephrocalcinosis	N/A